Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Vickers

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of the American Chemical Society|August 14, 2020
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These AgentsStanley T Crooke, Punit P Seth, Timothy A Vickers, et al.
Nucleic Acids Research|October 2, 2007
Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cellsTimothy A Vickers, Walt F Lima, Josh G Nichols, et al.
Nucleic Acids Research|February 12, 2021
Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteinsLingdi Zhang, Timothy A Vickers, Hong Sun, et al.
Plos One|July 30, 2014
Defining the factors that contribute to on-target specificity of antisense oligonucleotidesWalt F Lima, Timothy A Vickers, Josh Nichols, et al.
Nature Biotechnology|March 1, 2017
Cellular uptake and trafficking of antisense oligonucleotidesStanley T Crooke, Shiyu Wang, Timothy A Vickers, et al.
Plos One|October 22, 2014
Targeting of repeated sequences unique to a gene results in significant increases in antisense oligonucleotide potencyTimothy A Vickers, Susan M Freier, Huynh-Hoa Bui, et al.
American Journal of Human Genetics|March 29, 2008
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic miceYimin Hua, Timothy A Vickers, Hazeem L Okunola, et al.
Plos Biology|March 16, 2007
Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exonYimin Hua, Timothy A Vickers, Brenda F Baker, et al.
Nucleic Acids Research|June 6, 2019
mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathwayXue-Hai Liang, Joshua G Nichols, Chih-Wei Hsu, et al.
Nature Biotechnology|July 12, 2016
Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading framesXue-Hai Liang, Wen Shen, Hong Sun, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of the American Chemical Society|August 14, 2020
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These AgentsStanley T Crooke, Punit P Seth, Timothy A Vickers, et al.
Nucleic Acids Research|October 2, 2007
Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cellsTimothy A Vickers, Walt F Lima, Josh G Nichols, et al.
Nucleic Acids Research|February 12, 2021
Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteinsLingdi Zhang, Timothy A Vickers, Hong Sun, et al.
Plos One|July 30, 2014
Defining the factors that contribute to on-target specificity of antisense oligonucleotidesWalt F Lima, Timothy A Vickers, Josh Nichols, et al.
Nature Biotechnology|March 1, 2017
Cellular uptake and trafficking of antisense oligonucleotidesStanley T Crooke, Shiyu Wang, Timothy A Vickers, et al.
Plos One|October 22, 2014
Targeting of repeated sequences unique to a gene results in significant increases in antisense oligonucleotide potencyTimothy A Vickers, Susan M Freier, Huynh-Hoa Bui, et al.
American Journal of Human Genetics|March 29, 2008
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic miceYimin Hua, Timothy A Vickers, Hazeem L Okunola, et al.
Plos Biology|March 16, 2007
Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exonYimin Hua, Timothy A Vickers, Brenda F Baker, et al.
Nucleic Acids Research|June 6, 2019
mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathwayXue-Hai Liang, Joshua G Nichols, Chih-Wei Hsu, et al.
Nature Biotechnology|July 12, 2016
Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading framesXue-Hai Liang, Wen Shen, Hong Sun, et al.
Pageof 4